| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.5 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.097 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |